[HTML][HTML] Amorphous solid dispersions: role of the polymer and its importance in physical stability and in vitro performance

Q Shi, H Chen, Y Wang, R Wang, J Xu, C Zhang - Pharmaceutics, 2022 - mdpi.com
Amorphous solid dispersions stabilized by one or more polymer (s) have been widely used
for delivering amorphous drugs with poor water solubilities, and they have gained great …

Strategies to improve the stability of amorphous solid dispersions in view of the hot melt extrusion (HME) method

ALJ Khater, SH Almurisi, S Mahmood… - International Journal of …, 2023 - Elsevier
Oral administration of drugs is preferred over other routes for several reasons: it is non-
invasive, easy to administer, and easy to store. However, drug formulation for oral …

Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug–Polymer Compatibility Screening?

J Pavliš, A Mathers, M Fulem… - Molecular …, 2023 - ACS Publications
The bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs) can be
improved via the formulation of an amorphous solid dispersion (ASD), where the API is …

A rheological approach for predicting physical stability of amorphous solid dispersions

S Song, C Wang, B Zhang, CC Sun, TP Lodge… - Journal of …, 2023 - Elsevier
Miscibility is an important indicator of physical stability against crystallization of amorphous
solid dispersions (ASDs). Currently available methods for miscibility determination have …

[HTML][HTML] A hot-melt extrusion risk assessment classification system for amorphous solid dispersion formulation development

SO Kyeremateng, K Voges, S Dohrn, E Sobich… - Pharmaceutics, 2022 - mdpi.com
Several literature publications have described the potential application of active
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …

Effect of plasticizers on drug-in-adhesive patches containing 5-fluorouracil

S Kim, P Fouladian, F Afinjuomo, Y Song… - International Journal of …, 2022 - Elsevier
Abstract Topical patches containing 5-fluorouracil (5-FU) are a feasible alternative to
overcome the shortcomings of commercial cream for the treatment of non-melanoma skin …

Use of surfactant-based amorphous solid dispersions for BDDCS class II drugs to enhance oral bioavailability: A case report of resveratrol

X Jia, J Chen, H Cheng, X Pan, Y Ke, T Fu… - International Journal of …, 2023 - Elsevier
This paper aimed to improve in vitro dissolution/solubility as well as inhibit intestinal
metabolism and thus enhance oral bioavailability for a BDDCS class II drug by constructing …

[HTML][HTML] Composition Dependency of the Flory–Huggins Interaction Parameter in Drug–Polymer Phase Behavior

J Klueppelberg, UA Handge, M Thommes, J Winck - Pharmaceutics, 2023 - mdpi.com
An innovative strategy to address recent challenges in the oral administration of poorly
soluble drugs is the formulation of amorphous solid dispersions (ASDs), where the drug is …

Drug–drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs

H Wang, P Zhao, R Ma, J Jia, Q Fu - Drug Discovery Today, 2024 - Elsevier
Overcoming the poor water solubility of small-molecule drugs is a major challenge in the
development of clinical pharmaceuticals. Amorphization of crystalline drugs is a highly …

Molecular modeling and in vitro studies to assess solubility enhancement of nevirapine by solid dispersion technique

MRP Rao, AS Sonawane, SA Sapate, CH Mehta… - Journal of Molecular …, 2023 - Elsevier
Aim of this study was to improve nevirapine solubility using solid dispersion technique and
applying molecular modeling to assess drug-polymer interactions. Solid dispersions were …